Bendamustine (CAS 16506-27-7) — formula C16H21Cl2N3O2, molecular weight 358.3.
| CAS Number | 16506-27-7 |
|---|---|
| Molecular Formula | C16H21Cl2N3O2 |
| Molecular Weight | 358.3 |
| LogP | 0.44 |
| Applications | Uses: Alkylating drug indicated for the treatment of patients with chronic lymphocytic leukemia, Bandamustine hydrochloride, Bifunctional alkylating agent.[The Merck Index, Fourteenth Edition (2006), Therapeutic category: Antineoplastic, Formulations, Preparations: Parenteral: For injection, for IV infusion only: 100 mg Treanda (Cephalon)., Bendamustine hydrochloride, General Manufacturing Information: Approved for B-cell non-Hodgkin lymphoma |
Documented applications: Uses: Alkylating drug indicated for the treatment of patients with chronic lymphocytic leukemia, Bandamustine hydrochloride, Bifunctional alkylating agent.[The Merck Index, Fourteenth Edition (2006), Therapeutic category: Antineoplastic, Formulations, Preparations: Parenteral: For injection, for IV infusion only: 100 mg Treanda (Cephalon)., Bendamustine hydrochloride, General Manufacturing Information: Approved for B-cell non-Hodgkin lymphoma.
Bendamustine is a chemical compound with CAS registry number 16506-27-7 and molecular formula C16H21Cl2N3O2 (molecular weight 358.3).
CAS number: 16506-27-7
Its molecular formula C16H21Cl2N3O2 comprises 16 C, 21 H, 2 Cl, 3 N, 2 O atoms.
Also known as: Bendamustine · 苯达莫司汀
The CAS registry number of Bendamustine is 16506-27-7.
Molecular formula C16H21Cl2N3O2, molecular weight 358.3.
It is also registered under: Bendamustine, 苯达莫司汀.
Recorded applications: Uses: Alkylating drug indicated for the treatment of patients with chronic lymphocytic leukemia, Bandamustine hydrochloride, Bifunctional alkylating agent.[The Merck Index, Fourteenth Edition (2006), Therapeutic category: Antineoplastic, Formulations, Preparations: Parenteral: For injection, for IV infusion only: 100 mg Treanda (Cephalon)., Bendamustine hydrochloride, General Manufacturing Information: Approved for B-cell non-Hodgkin lymphoma.
Independent reference data for Bendamustine (CAS 16506-27-7), compiled from public chemistry databases.
| CAS Registry Number | 16506-27-7 |
|---|---|
| PubChem CID | 65628 |
| Molecular formula | C16H21Cl2N3O2 |
| IUPAC name | 4-[5-[bis(2-chloroethyl)amino]-1-methylbenzimidazol-2-yl]butanoic acid |
| UNII (FDA) | 9266D9P3PQ |
| Molecular Weight | 358.3 |
|---|---|
| XLogP3 | 2.9 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 9 |
| Exact Mass | 357.1010823 |
| Monoisotopic Mass | 357.1010823 |
| Topological Polar Surface Area | 58.4 |
| Heavy Atom Count | 23 |
| LogP | 0.44 |
|---|
Bendamustine; 16506-27-7; Bendamustina; 4-[5-[bis(2-chloroethyl)amino]-1-methylbenzimidazol-2-yl]butanoic acid; Bendamustinum; DTXSID2046888; 9266D9P3PQ; 1H-Benzimidazole-2-butanoic acid, 5-(bis(2-chloroethyl)amino)-1-methyl-; DTXCID0026888; 5-(Bis(2-chloroethyl)amino)-1-methyl-2-benzimidazolebutyric acid; 4-{5-[bis(2-chloroethyl)amino]-1-methyl-1H-1,3-benzodiazol-2-yl}butanoic acid; omega-(1-Methyl-5-bis(beta-chloroethyl)aminobenzimidazole-(2)-butyric acid; 1H-benzimidazole-2-butanoic acid, 5-[bis(2-chloroethyl)amino]-1-methyl-; 4-(5-(bis(2-chloroethyl)amino)-1-methylbenzimidazol-2-yl)butanoic acid; 4-(5-(bis(2-chloroethyl)amino)-1-methyl-1H-1,3-benzodiazol-2-yl)butanoic acid; RefChem:54437
| Reported hazard statements | H301 (100%), H341 (100%), H351 (100%), H360 (100%) |
|---|
H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral]
H341 (100%): Suspected of causing genetic defects [Warning Germ cell mutagenicity]
Bendamustine · CAS 16506-27-7 · C16H21Cl2N3O2. UNII 9266D9P3PQ. LogP: 0.44.
Source: PubChem / Wikidata; the batch COA governs where values differ.
Supplier: Jinan Shenghe Chemical Co., Ltd.
中文页面: 苯达莫司汀